secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001628280-25-003073
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology CTO to depart Feb 26; Maninder Hora appointed as replacement
------------------------------------------------------------------------------

- Ann (Aine) M. Hanly, EVP and Chief Technology Officer, will leave Vir Biotechnology on February 26, 2025.
- Maninder Hora, Ph.D. appointed as EVP and Chief Technical Operations Officer, effective February 27, 2025.
- Dr. Hora will assume all responsibilities formerly held by Dr. Hanly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/0001628280-25-003073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/vir-20250124.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-003073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer